MERCK Kommanditgesellschaft auf Aktien (MKGAF PINK) stock market data APIs
$127.3833
0(0%)
as of September 15, 2025
Try our APIs with
free plan!
MERCK Kommanditgesellschaft auf Aktien Financial Data Overview
Price chart is built with
Anychart
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector. This segment also provides drug manufacturers with process development expertise and technologies, such as continuous bioprocessing; testing kits and services; reagents and services; testing solutions that analyze air, water, and soil; and testing and tools, as well as products that help test nutritional value and identify quality inconsistencies. The Healthcare segment discovers, develops, manufacturers, and markets prescription drugs and biopharmaceuticals for the treatment of oncology, neurology and immunology, fertility, endocrinology, as well as cardiovascular, diabetes, thyroid disorders, and multiple sclerosis; general medicines; and injection device and disease monitoring software. The Electronics segment supplies materials for the semiconductor and display industries and surface design, such as delivery systems and services, as well as surface solutions, including cosmetics, effect pigments, and functional solutions. In addition, it has in-licensing agreement with Debiopharm International SA for developing and commercializing drug candidates for the treatment of head and neck cancer; Jiangsu Hengrui Pharmaceuticals Co. Ltd. for developing, manufacturing, and commercializing drug candidates for the treatment of metastatic colorectal cancer; and Abbisko Therapeutics Co. Ltd. for developing and commercializing of drug candidates for the treatment of tenosynovial giant cell tumor, as well as license and collaboration agreement with Merck KGaA to discover two targeted protein degraders against critical oncogenic proteins. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Prev. Close
127.3833
Open
127.3833
High
127.3833
Low
127.3833
52 wk Range
114.0023-183.8956
Market Cap
54 901 M
P/E Ratio
16.0043
Shares Outstanding
129 M
Revenue
21 219 M
EPS
1.7011
Dividends (Yield)
0.0169
Beta
0.61
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MERCK Kommanditgesellschaft auf Aktien data using free add-ons & libraries
Get MERCK Kommanditgesellschaft auf Aktien Fundamental Data
MERCK Kommanditgesellschaft auf Aktien Fundamental data includes:
- Net Revenue: 21 219 M
- EBITDA: 5 953 M
- Earnings Per Share: 7
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-07
- EPS/Forecast: 2.14
Get MERCK Kommanditgesellschaft auf Aktien End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MERCK Kommanditgesellschaft auf Aktien News
New
Saisei Ventures Appoints James Feliciano as Venture Partner
James Feliciano, Venture Partner CAMBRIDGE, Mass., September 15, 2025--(BUSINESS WIRE)--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovati...
Notable healthcare headlines for the week: Novo Nordisk, Novartis and UnitedHealth in focus
Wall Street's major averages closed mixed on Friday, with the Nasdaq Composite (COMP:IND [https://seekingalpha.com/symbol/COMP:IND]) closing at new highs every day of the week, while the Dow (DJI [htt...
Is This the Right Moment to Revisit Merck KGaA After Its Sharp 35% Slide?
Wondering whether Merck KGaA is the fresh opportunity your portfolio needs, or a value trap waiting to spring? You are not alone, especially as the company’s shares have been on a wild ride lately. ...
Trump is said to force Big Pharma to lower drug prices within weeks
[New York Marks 24th Anniversary Of September 11 Terror Attacks] Michael M. Santiago/Getty Images News President Donald Trump is exerting pressure on major pharmaceutical companies to lower drug pric...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
